WithdrawnNCT00359125
RU-486 in the Treatment of Depression in bipolarity
Medication studyAges 19–65Canada
Understand this study
Who could participate?
Listed age limits: 19 years to 65 years.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateJuly 2006
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 19 Years to 65 Years
- Official registry ID
- NCT00359125
- Official title
Show the full official title
Efficacy of Mifepristone (RU-486) in the Treatment of Bipolar Depression.
Recruitment & locations
WithdrawnVancouver
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Does this study involve medication?
Yes. The study involves medication, including mifepristone (RU-486).
Who can participate?
Listed age limits: 19 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
